Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Changjiang Pharmaceutical Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
Changjiang Pharmaceutical Group has a total shareholder equity of CN¥775.6M and total debt of CN¥969.6M, which brings its debt-to-equity ratio to 125%. Its total assets and total liabilities are CN¥3.1B and CN¥2.3B respectively.
Anahtar bilgiler
125.0%
Borç/özkaynak oranı
CN¥969.62m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥10.06m |
| Eşitlik | CN¥775.62m |
| Toplam yükümlülükler | CN¥2.33b |
| Toplam varlıklar | CN¥3.11b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30
Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 300391's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥1.8B).
Uzun Vadeli Yükümlülükler: 300391's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥550.7M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 300391's net debt to equity ratio (123.7%) is considered high.
Borcun Azaltılması: 300391's debt to equity ratio has increased from 17.9% to 125% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: 300391 has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: 300391 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 43.2% each year